Bergmann Anthony
Transaction: 06/24/2026
SELL
Change
-400
Price
$30.00
Filing
06/24/2026
Type
SELL
Capricor Therapeutics, Inc.
CAPR • Biotechnology
$9.40
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$539.88M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 290.7%Manageable debt level · 0.07Healthy liquidity · 9.01Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$9.40
Change0.00%
Shares Out57.43M
Market Cap$539.88M
Enterprise Value$268.45M
52W Range4.30 - 40.37
Beta0.37
P/E-4.71
P/B1.94
P/FCF-0.25
EV/EBITDA-2.29
EV/FCF-0.13
Price$9.40
Change0.00%
Shares Out57.43M
Market Cap$539.88M
Enterprise Value$268.45M
52W Range4.30 - 40.37
Beta0.37
P/E-4.71
P/B1.94
P/FCF-0.25
EV/EBITDA-2.29
EV/FCF-0.13
Earnings Yield-21.23%
FCF Yield-392.18%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.07
Current Ratio9.01
Quick Ratio9.01
Target$10.63
Target Upside13.09%
Target Median$7.00
Target Range3.50 - 25.00
Volume773.11K
Avg Volume1.04M
EPS Surprise-0.04
Investment DNA
How strong this company looks for long-term investors
52
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
67/100
Why this score▼
Positive revenue growth · 290.7%Manageable debt level · 0.07Healthy liquidity · 9.01Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 10 analyst votes · 2026-09-05
90/100
Bullish
Bullish
8
Hold
2
Bearish
0
Price Target
2026-06-25
Low
$38.00
Mean
$50.00
Median
$50.00
High
$62.00
Insider Transactions
Recent executive and insider activity
Bergmann Anthony
Transaction: 06/24/2026
SELL
Change
-400
Price
$3.18
Filing
06/24/2026
Type
SELL
Krasney Karen
Transaction: 06/24/2026
SELL
Change
-400
Price
$30.00
Filing
06/24/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Bergmann Anthony | SELL | -400 | $30.00 | 06/24/2026 | 06/24/2026 |
| Bergmann Anthony | SELL | -400 | $3.18 | 06/24/2026 | 06/24/2026 |
| Krasney Karen | SELL | -400 | $30.00 | 06/24/2026 | 06/24/2026 |
| Krasney Karen | SELL | -400 | $3.18 | 06/24/2026 | 06/24/2026 |
| Bergmann Anthony | BUY | +500 | $3.18 | 06/22/2026 | 06/24/2026 |
| Bergmann Anthony | SELL | -500 | $3.18 | 06/22/2026 | 06/24/2026 |
| Krasney Karen | BUY | +500 | $3.18 | 06/22/2026 | 06/24/2026 |
| Krasney Karen | SELL | -500 | $3.18 | 06/22/2026 | 06/24/2026 |
| Maurer Michael T | BUY | +80,000 | $29.36 | 05/26/2026 | 05/28/2026 |
| Maurer Michael T | OTHER | 0 | Not reported | 05/25/2026 | 05/28/2026 |
| Bergmann Anthony | SELL | -3,000 | $1.39 | 05/18/2026 | 05/19/2026 |
| Bergmann Anthony | BUY | +3,000 | $1.39 | 05/18/2026 | 05/19/2026 |
| Litvack Frank | SELL | -3,937 | $1.39 | 05/13/2026 | 05/14/2026 |
| Litvack Frank | BUY | +3,937 | $1.39 | 05/13/2026 | 05/14/2026 |
| Bergmann Anthony | SELL | -25,000 | $31.70 | 05/01/2026 | 05/04/2026 |
| Bergmann Anthony | SELL | -25,000 | $3.18 | 05/01/2026 | 05/04/2026 |
| Krasney Karen | SELL | -25,000 | $31.70 | 05/01/2026 | 05/04/2026 |
| Krasney Karen | SELL | -25,000 | $3.18 | 05/01/2026 | 05/04/2026 |
| Sabar Karimah Es | SELL | -7,529 | $3.18 | 04/02/2026 | 04/03/2026 |
| Sabar Karimah Es | SELL | -7,529 | $32.00 | 04/02/2026 | 04/03/2026 |